Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://scidar.kg.ac.rs/handle/123456789/11801
Пун извештај метаподатака
Поље DC-а ВредностЈезик
dc.rights.licenserestrictedAccess-
dc.contributor.authorStokanovic, Dragana-
dc.contributor.authorNikolic V.-
dc.contributor.authorKonstantinovic, Sandra-
dc.contributor.authorZvezdanović, Jelena-
dc.contributor.authorLilic J.-
dc.contributor.authorApostolovic, Svetlana-
dc.contributor.authorPavlović, Milan-
dc.contributor.authorZivkovic V.-
dc.contributor.authorJevtovic Stoimenov, Tatjana-
dc.contributor.authorJankovic, Slobodan-
dc.date.accessioned2021-04-20T19:15:43Z-
dc.date.available2021-04-20T19:15:43Z-
dc.date.issued2016-
dc.identifier.issn0031-7012-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/11801-
dc.description.abstract© 2015 S. Karger AG, Basel. Background/Aims: One of the most common polymorphisms of ABCB1 gene, a synonymous mutation C3435T (rs1045642), is associated with increased in vivo activity. The main goal of this study was to determine the association of C3435T polymorphism with clopidogrel and 2-oxo-clopidogrel concentrations in plasma. Methods: The patients were recruited upon acute myocardial infarction diagnosis. They were all tested for ABCB1 C3435T polymorphism. In plasma, drawn 1 h after the drug administration, concentrations of clopidogrel and 2-oxo-clopidogrel were measured using UHPLC-DAD-MS analysis. Results: Due to differences in the maintenance doses, we have calculated the dose-adjusted concentrations of clopidogrel (0.2 ng/ml/mg (0.1-0.4)) and 2-oxo-clopidogrel (2.1 ng/ml/mg (0.5-4.6)). Patients carrying at least one C allele achieved significantly higher serum concentration of clopidogrel (p < 0.001), as well as dose-adjusted clopidogrel (p < 0.001) and 2-oxo-clopidogrel concentrations (p < 0.05). Conclusion: The ABCB1 3435CC genotype is associated with increased clopidogrel and 2-oxo-clopidogrel dose-adjusted concentrations. Therefore, the ABCB1 C3435T genotyping should be one of the parameters taken into account when deciding about the dosing regimen of clopidogrel.-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourcePharmacology-
dc.titleP-Glycoprotein Polymorphism C3435T Is Associated with Dose-Adjusted Clopidogrel and 2-Oxo-Clopidogrel Concentration-
dc.typearticle-
dc.identifier.doi10.1159/000442712-
dc.identifier.scopus2-s2.0-84953707751-
Налази се у колекцијама:Faculty of Medical Sciences, Kragujevac

Број прегледа

738

Број преузимања

17

Датотеке у овој ставци:
Датотека Опис ВеличинаФормат 
PaperMissing.pdf
  Ограничен приступ
29.86 kBAdobe PDFСличица
Погледајте


Ставке на SCIDAR-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.